Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)

Introduction: The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines for Glomerulonephritis recommend that patients with membranous nephropathy (MN) at risk for progression receive immunosuppressive therapy (IST), usually after 6 months of observation. A cyclophospha...

Full description

Bibliographic Details
Main Authors: Michelle M. O’Shaughnessy, Jonathan P. Troost, Andrew S. Bomback, Michelle A. Hladunewich, Isa F. Ashoor, Keisha L. Gibson, Raed Bou Matar, David T. Selewski, Tarak Srivastava, Michelle N. Rheault, Amira Al-Uzri, Amy J. Kogon, Myda Khalid, Suzanne Vento, Neil S. Sanghani, Brenda W. Gillespie, Debbie S. Gipson, Chia-shi Wang, Afshin Parsa, Lisa Guay-Woodford, Louis-Philippe Laurin
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024919314834